CAJ | 학술논문

通过对润湿分散剂、防冻剂、增稠剂的筛选，确定了15％甲维·吡虫啉悬浮剂优惠配方：78．2％甲维盐原药6．5％，95．6％吡虫啉原药10．6％，润湿分散剂GY—SC853．0％，防冻剂尿素4．0％，增稠剂黄原胶0．2％、硅酸镁铝0．5％，消泡剂GY—X600．2％，水75．0％。该优惠配方制备的悬浮剂低温和热贮后物理化学性质稳定。
통과대윤습분산제、방동제、증주제적사선，학정료15％갑유·필충람현부제우혜배방：78．2％갑유염원약6．5％，95．6％필충람원약10．6％，윤습분산제GY—SC853．0％，방동제뇨소4．0％，증주제황원효0．2％、규산미려0．5％，소포제GY—X600．2％，수75．0％。해우혜배방제비적현부제저온화열저후물이화학성질은정。
The optimum 15% suspension concentrate formulation of emamectin benzoate and imidacloprid was developed by screening wetting and dispersing agents, anti - freezer, thickener, which consists of 78.2% emamectin benzoate (6.5%), 95.6% imidacloprid ( 10.6% ), wetting dispersant GY - SC85 (3.0%), anti - freezer urea (4.0%), thickener (0.2% xanthan gum and 0.5% magnesium aluminum silicates), defoamer GY - X60 (0.2%), and water (75.0%). The physical and chemical properties of the formulation did not change significantly after it was stored under -1℃and 54℃ conditions for 14 days.